PE20061361A1 - Uso de derivados de 4-piridilmetil-ftalacina como inhibidores de vegf-r - Google Patents
Uso de derivados de 4-piridilmetil-ftalacina como inhibidores de vegf-rInfo
- Publication number
- PE20061361A1 PE20061361A1 PE2006000398A PE2006000398A PE20061361A1 PE 20061361 A1 PE20061361 A1 PE 20061361A1 PE 2006000398 A PE2006000398 A PE 2006000398A PE 2006000398 A PE2006000398 A PE 2006000398A PE 20061361 A1 PE20061361 A1 PE 20061361A1
- Authority
- PE
- Peru
- Prior art keywords
- phthalkine
- vegf
- inhibitors
- capillary
- patients
- Prior art date
Links
- 229940124674 VEGF-R inhibitor Drugs 0.000 title 1
- -1 4-PYRIDYL Chemical class 0.000 abstract 3
- 108091008605 VEGF receptors Proteins 0.000 abstract 2
- 102000009484 Vascular Endothelial Growth Factor Receptors Human genes 0.000 abstract 2
- 229940124676 vascular endothelial growth factor receptor Drugs 0.000 abstract 2
- YCOYDOIWSSHVCK-UHFFFAOYSA-N vatalanib Chemical compound C1=CC(Cl)=CC=C1NC(C1=CC=CC=C11)=NN=C1CC1=CC=NC=C1 YCOYDOIWSSHVCK-UHFFFAOYSA-N 0.000 abstract 2
- 229950000578 vatalanib Drugs 0.000 abstract 2
- 206010009944 Colon cancer Diseases 0.000 abstract 1
- 208000001333 Colorectal Neoplasms Diseases 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 230000000340 anti-metabolite Effects 0.000 abstract 1
- 229940100197 antimetabolite Drugs 0.000 abstract 1
- 239000002256 antimetabolite Substances 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 230000002496 gastric effect Effects 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
- 208000020816 lung neoplasm Diseases 0.000 abstract 1
- 230000001537 neural effect Effects 0.000 abstract 1
- DWAFYCQODLXJNR-BNTLRKBRSA-L oxaliplatin Chemical compound O1C(=O)C(=O)O[Pt]11N[C@@H]2CCCC[C@H]2N1 DWAFYCQODLXJNR-BNTLRKBRSA-L 0.000 abstract 1
- 229960001756 oxaliplatin Drugs 0.000 abstract 1
- 150000003058 platinum compounds Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
SE REFIERE AL USO DE INHIBIDORES DE RECEPTOR DE FACTOR DE CRECIMIENTO ENDOTELIAL VASCULAR (VEGF-R) TAL COMO UN DERIVADO DE 4-PIRIDILMETIL-FTALACINA DE FORMULA (I), SIENDO PREFERIDO EL COMPUESTO PTK787 O PTK/ZK O N-(4-CLOROFENIL)-4-(4-PIRIDINILMETIL)-FTALACINAMINA O TAMBIEN DENOMINADO VATALANIB, SOLO O EN COMBINACION CON AL MENOS UN COMPUESTO DE PLATINO TAL COMO OXALIPLATINA Y/O UN ANTIMETABOLITO ANTINEOPLASICO TAL COMO 5-FLUOROURACILO, CAPECITABINA Y OPCIONALMENTE ACIDO FOLINICO, ENTRE OTROS. PARA EL TRATAMIENTO DE PACIENTES CON CANCER GASTROINTESTINAL, GENITOURINARIO, LINFOIDE Y PULMONAR O CANCER DE ORIGEN CRESTA NEURAL, EN ESPECIAL CANCER COLORECTAL, A PACIENTES QUE TIENE ALTO VALORES DE LDH
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US67087005P | 2005-04-13 | 2005-04-13 | |
| US68039605P | 2005-05-12 | 2005-05-12 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20061361A1 true PE20061361A1 (es) | 2007-01-03 |
Family
ID=36649704
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2006000398A PE20061361A1 (es) | 2005-04-13 | 2006-04-17 | Uso de derivados de 4-piridilmetil-ftalacina como inhibidores de vegf-r |
Country Status (6)
| Country | Link |
|---|---|
| AR (1) | AR053576A1 (es) |
| GT (1) | GT200600147A (es) |
| PE (1) | PE20061361A1 (es) |
| TW (1) | TW200719914A (es) |
| UY (1) | UY29471A1 (es) |
| WO (1) | WO2006113172A1 (es) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0610925D0 (en) * | 2006-06-02 | 2006-07-12 | Novartis Ag | Use of vascular endothelial growth factor receptor inhibitors for the treatment of cancer |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CO4950519A1 (es) * | 1997-02-13 | 2000-09-01 | Novartis Ag | Ftalazinas, preparaciones farmaceuticas que las comprenden y proceso para su preparacion |
-
2006
- 2006-04-10 GT GT200600147A patent/GT200600147A/es unknown
- 2006-04-10 WO PCT/US2006/013056 patent/WO2006113172A1/en not_active Ceased
- 2006-04-11 AR ARP060101427A patent/AR053576A1/es not_active Application Discontinuation
- 2006-04-11 UY UY29471A patent/UY29471A1/es not_active Application Discontinuation
- 2006-04-12 TW TW095113028A patent/TW200719914A/zh unknown
- 2006-04-17 PE PE2006000398A patent/PE20061361A1/es not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| GT200600147A (es) | 2006-11-24 |
| AR053576A1 (es) | 2007-05-09 |
| UY29471A1 (es) | 2006-11-30 |
| WO2006113172A1 (en) | 2006-10-26 |
| TW200719914A (en) | 2007-06-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2009011964A (es) | Derivados heterociclicos pirrolo-nitrogenosos, su preparacion y uso farmaceutico. | |
| PE20090714A1 (es) | Imidazopiridazinas y pirrolo-pirimidinas sustituidas como inhibidores de cinasa de lipido | |
| CO6180480A2 (es) | Pirimidinilpirazoles como principios activos insecticidas y parasiticidas | |
| TW200607804A (en) | Pyridazinone derivatives, methods for producing them and their use as pharmaceuticals | |
| DE602004022404D1 (de) | 4-anilino-chinazolin-derivate als proliferationshemmende mittel | |
| EA200870217A1 (ru) | 4-арил-2-аминопиримидины или 4-арил-2-аминоалкилпиримидины в качестве модуляторов jak-2 и содержащие их фармацевтические композиции | |
| NO20083923L (no) | Pyrazolkinoloner er potente parp-inhibitorer | |
| CL2008003691A1 (es) | Compuestos derivados de 4-(fenil o piridin) pirimidina, inhibidores de la elastasa neutrofila humana; procedimiento de preparacion; composicion farmaceutica; y uso para el tratamiento y/o la prevencion de hipertension arterial pulmonar, epoc, enfisema pulmonar, entre otras. | |
| MX2008005398A (es) | Derivados de 4-(3-amino-pirazol)-pirimidina para uso como inhibidores de tirosina cinasa en el tratamiento de cancer. | |
| UA94129C2 (ru) | Соединения для ингибирования митоза | |
| DE602004011199D1 (de) | 5-phenylthiazolderivate und deren verwendung als p13-kinase-inhibitoren | |
| ATE537830T1 (de) | Nicotinamid derivate und ihre verwendung als therapeutika | |
| TN2010000053A1 (fr) | Derives de bi cyclolactames substitues | |
| ATE469158T1 (de) | Heteroalkylgebundene pyrimidinderivate | |
| BRPI0615111B8 (pt) | composto, composição farmacêutica, e, uso do composto | |
| CY1115952T1 (el) | Παραγωγα πυραζολο πυριδινης σαν αναστολεις της οξειδασης nadρη | |
| CY1111069T1 (el) | Παραγωγα διυδροπυραζολοπυριμιδινονης | |
| BRPI0514125A (pt) | piridinas condensadas como inibidores de cinase | |
| ATE502038T1 (de) | Azyklische amininhibitoren von nukleosidphosphorylasen und hydrolasen | |
| ATE406351T1 (de) | Kondensierte heteroyralderivate zur verwendung als p38-kinase-inhibitoren | |
| PE20090288A1 (es) | Derivados de quinoxalina como inhibidores de la pi3 quinasa | |
| NZ594385A (en) | Aminopyrimidines useful as kinase inhibitors | |
| NO20084418L (no) | Azolopyridin-3-on derivater som inhibitorer av endoteliallipase | |
| CY1113556T1 (el) | Παραγωγα πυραζολο πυριδινης ως αναστολεις της nadph οξειδασης | |
| MY153727A (en) | Pyridazinone derivatives |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |